Suppr超能文献

外周大麻素可减轻小鼠体内癌诱导的伤害感受。

Peripheral cannabinoids attenuate carcinoma-induced nociception in mice.

作者信息

Guerrero Andre V, Quang Phuong, Dekker Nusi, Jordan Richard C K, Schmidt Brian L

机构信息

UCSF School of Dentistry, University of California, Sa Francisco, CA 94143-0440, United States.

出版信息

Neurosci Lett. 2008 Mar 12;433(2):77-81. doi: 10.1016/j.neulet.2007.12.053. Epub 2008 Jan 8.

Abstract

We investigated the cannabinoid receptor (CBr) agonists Win55,212-2 (non-selective) and AM1241 (CBr2 selective) and the peripheral receptor (CBr1) in carcinoma-induced pain using a mouse model. Tumors were induced in the hind paw of female mice by local injection of a human oral squamous cell carcinoma (SCC). Significant pain, as indicated by reduction in withdrawal thresholds in response to mechanical stimulation, began at 4 days after SCC inoculation and lasted to 18 days. Local administration of Win55,212-2 (10 mg/kg) and AM1241 (10 mg/kg) significantly elevated withdrawal thresholds, indicating an antinociceptive effect. Ipsilateral expression of CBr1 protein in L5 DRG was significantly upregulated compared to ipsilateral L4 DRG and in normal tissue. These findings support the suggestion that cannabinoids are capable of producing antinociception in carcinoma-induced pain.

摘要

我们使用小鼠模型研究了大麻素受体(CBr)激动剂Win55,212-2(非选择性)和AM1241(CBr2选择性)以及外周受体(CBr1)在癌痛中的作用。通过局部注射人口腔鳞状细胞癌(SCC)在雌性小鼠后爪诱导肿瘤。接种SCC后4天开始出现明显疼痛,表现为对机械刺激的撤针阈值降低,并持续至18天。局部给予Win55,212-2(10mg/kg)和AM1241(10mg/kg)可显著提高撤针阈值,表明具有抗伤害感受作用。与同侧L4背根神经节(DRG)和正常组织相比,L5 DRG中CBr1蛋白的同侧表达显著上调。这些发现支持了大麻素能够在癌痛中产生抗伤害感受的观点。

相似文献

1
Peripheral cannabinoids attenuate carcinoma-induced nociception in mice.
Neurosci Lett. 2008 Mar 12;433(2):77-81. doi: 10.1016/j.neulet.2007.12.053. Epub 2008 Jan 8.
3
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.
Pain. 1999 Aug;82(2):199-205. doi: 10.1016/S0304-3959(99)00045-7.
4
Cannabinoids attenuate cancer pain and proliferation in a mouse model.
Neurosci Lett. 2011 Jan 25;488(3):247-51. doi: 10.1016/j.neulet.2010.11.039. Epub 2010 Nov 19.
8
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.
Neuroscience. 2012 Feb 17;203:180-93. doi: 10.1016/j.neuroscience.2011.12.028. Epub 2011 Dec 22.
9
Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain.
Eur J Pain. 2007 May;11(4):406-14. doi: 10.1016/j.ejpain.2006.05.007. Epub 2006 Jun 27.
10
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
Neurosci Lett. 2011 Apr 15;493(3):67-71. doi: 10.1016/j.neulet.2010.12.052. Epub 2010 Dec 31.

引用本文的文献

2
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients.
Pharmaceuticals (Basel). 2020 Nov 30;13(12):435. doi: 10.3390/ph13120435.
3
Opportunities for cannabis in supportive care in cancer.
Ther Adv Med Oncol. 2019 Aug 1;11:1758835919866362. doi: 10.1177/1758835919866362. eCollection 2019.
4
Cannabinoids and Pain: New Insights From Old Molecules.
Front Pharmacol. 2018 Nov 13;9:1259. doi: 10.3389/fphar.2018.01259. eCollection 2018.
5
The neurobiology of cancer pain.
Neuroscientist. 2014 Oct;20(5):546-62. doi: 10.1177/1073858414525828. Epub 2014 Mar 24.
6
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells.
J Pharmacol Exp Ther. 2014 Feb;348(2):293-302. doi: 10.1124/jpet.113.205120. Epub 2013 Nov 20.
7
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain.
Neuroscience. 2013 Sep 5;247:84-94. doi: 10.1016/j.neuroscience.2013.05.003. Epub 2013 May 11.
8
Dynamic changes to the endocannabinoid system in models of chronic pain.
Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3300-11. doi: 10.1098/rstb.2011.0390.
9
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats.
Pain. 2012 Nov;153(11):2283-2291. doi: 10.1016/j.pain.2012.07.037. Epub 2012 Aug 31.
10
Biologic mechanisms of oral cancer pain and implications for clinical therapy.
J Dent Res. 2012 May;91(5):447-53. doi: 10.1177/0022034511424156. Epub 2011 Oct 4.

本文引用的文献

1
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.
J Neuroimmunol. 2007 Sep;189(1-2):17-22. doi: 10.1016/j.jneuroim.2007.06.001. Epub 2007 Jul 19.
2
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.
Nat Neurosci. 2007 Jul;10(7):870-9. doi: 10.1038/nn1916. Epub 2007 Jun 10.
3
Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
Eur J Pharmacol. 2007 Mar 8;558(1-3):73-87. doi: 10.1016/j.ejphar.2006.11.062. Epub 2006 Dec 9.
5
Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.
Pain. 2006 Dec 15;126(1-3):102-14. doi: 10.1016/j.pain.2006.06.016. Epub 2006 Jul 14.
6
Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain.
Eur J Pain. 2007 May;11(4):406-14. doi: 10.1016/j.ejpain.2006.05.007. Epub 2006 Jun 27.
7
CB2 cannabinoid receptor mediation of antinociception.
Pain. 2006 May;122(1-2):36-42. doi: 10.1016/j.pain.2005.12.018. Epub 2006 Mar 23.
8
Synaptic modulation in pain pathways.
Rev Physiol Biochem Pharmacol. 2005;154:73-100. doi: 10.1007/s10254-005-0043-y.
9
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3093-8. doi: 10.1073/pnas.0409888102. Epub 2005 Feb 10.
10
Evaluation of pain in patients with oral squamous cell carcinoma.
J Pain. 2004 Nov;5(9):505-10. doi: 10.1016/j.jpain.2004.09.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验